Added to YB: 2025-10-29
Pitch date: 2025-10-27
WHWK [bullish]
Whitehawk Therapeutics, Inc.
+77.69%
current return
Author Info
Lionheart’s Newsletter is for presenting and discussing investment ideas in anything weird, obscure or underfollowed. I just want to turn over rocks and have fun! Sign up for the newsletter.
Company Info
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.
Market Cap
$194.7M
Pitch Price
$2.42
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.58
P/E
-2.36
EV/Sales
N/A
Sector
Biotechnology
Category
value
International Markets, Dirt Cheap Solar Play and This Week's Bio-Tech Net Net - Whitehawk Therapeutics, Inc.
WHWK: Bio-tech net net w/ $168M net cash vs $110M market cap. Heavy cash burn $20-96M annually gives 1-2yr runway. 6mo options dropped 40% making them attractive vs 50% total loss risk. Basket approach for D-tier bio-techs trading below cash value.
Read full article (1 min)